UPMC Hillman Cancer Center at UPMC Passavant — Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center at UPMC Passavant is a clinical research site located in Pittsburgh, Pennsylvania, United States 15237-9643.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center at UPMC Passavant has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer.

Sponsors: CanariaBio Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center at UPMC Passavant?

UPMC Hillman Cancer Center at UPMC Passavant has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center at UPMC Passavant conducted?

UPMC Hillman Cancer Center at UPMC Passavant has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer.

Is UPMC Hillman Cancer Center at UPMC Passavant accredited by Crixeo Health?

UPMC Hillman Cancer Center at UPMC Passavant has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center at UPMC Passavant?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.